← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 1999First marketed drug
Jul 13, 1984First NDA
Jul 13, 1984Last known activity
Jun 15, 2023
Timeline
1980s
- Jul 1, 1982
Braintree Laboratories— Founded
- Jul 13, 1984
potassium chloride— NDA Secondary Org
- Jul 13, 1984
sodium sulfate— NDA Organization
2010s
- Jan 18, 2013
polyethylene glycol— Marketing Organization
Drugs by trial phase (19 distinct, 49 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (11)
Recent trials (50)
- NCT05890001Lead sponsorPhase 3Apr 5, 2023
- NCT05587309Lead sponsorPhase 3Nov 30, 2022
- NCT05587322Lead sponsorPhase 3Sep 6, 2022
- NCT04446299Lead sponsorPhase 3Jul 13, 2020
- NCT04446312Lead sponsorPhase 3Jul 13, 2020
- NCT04214301Lead sponsorPhase 4Sep 24, 2019
- NCT04214301Study directorPhase 4Sep 24, 2019
- NCT03404401Lead sponsorPhase 3Jan 11, 2018
- NCT03404401Study directorPhase 3Jan 11, 2018
- NCT03328507Lead sponsorPhase 2Nov 9, 2017
- NCT03328507Study directorPhase 2Nov 9, 2017
- NCT03261960Study directorPhase 3Aug 8, 2017
- NCT03261960Lead sponsorPhase 3Aug 8, 2017
- NCT03103581Lead sponsorPhase 2Feb 16, 2017
- NCT03103581Study directorPhase 2Feb 16, 2017
Details
- Founded
- Braintree, MA, US Jul 1, 1982
- First NDA
- Jul 13, 1984
- Last known activity
- Jun 15, 2023
Notes
Acquired by Sebela Pharma